Highlights

  1. Home
  2. Highlights

North American Spine Society (NASS) 2026

Regenity Biosciences is heading to NASS 2026, October 14-17 in San Antonio, TX at the Henry B….

Read More

Please join us in welcoming Phil Stead as Regenity Bioscience’s new Chief Revenue Officer.

Phil brings more than 20 years of commercial leadership in medical technology, with roles at…

Read More

Join Regenity at MD&M Midwest 2026

Regenity Biosciences is heading to MD&M Midwest 2026, October 28-29 at the Minneapolis…

Read More

Regenity Biosciences Announces New Allendale Campus, Fueled by Record Growth and an Expanding Product Pipeline

14th April 2026 Regenity Biosciences today announced the signing of a lease on a new facility in…

Read More

Regenity Biosciences Strengthens Executive Leadership Team with Two Strategic Appointments, Advancing its Mission to Lead the Next Generation of Regenerative Devices

14th April 2026 Company promotes Peggy Hansen to Chief Innovation & Strategy Officer and…

Read More

Regenity Biosciences receives strategic investment from Cinven, adding new partner alongside Linden Capital Partners

12th February 2026 Transaction will establish partnership between Regenity, Cinven, and legacy…

Read More

Let’s Connect

Looking for a reliable partner to fill your product portfolio gap, co-create your next great innovation or manufacture your products?
Let’s Connect